1. Home
  2. PRQR vs ACR Comparison

PRQR vs ACR Comparison

Compare PRQR & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.72

Market Cap

167.5M

Sector

Health Care

ML Signal

HOLD

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$19.06

Market Cap

134.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
ACR
Founded
2012
2005
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
167.5M
134.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
ACR
Price
$1.72
$19.06
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$6.80
$24.50
AVG Volume (30 Days)
406.3K
15.5K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.76
N/A
P/E Ratio
N/A
$19.59
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$16.51
52 Week High
$3.10
$24.61

Technical Indicators

Market Signals
Indicator
PRQR
ACR
Relative Strength Index (RSI) 51.70 51.27
Support Level $1.34 $18.73
Resistance Level $2.30 $19.64
Average True Range (ATR) 0.14 0.41
MACD 0.02 0.01
Stochastic Oscillator 61.90 43.14

Price Performance

Historical Comparison
PRQR
ACR

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: